Suppr超能文献

脑卒中患者接受肉毒毒素注射后肢体功能变化的多维评估。

Multidimensional evaluation of changes in limb function following botulinum toxin injection in persons with stroke.

机构信息

Department of Rehabilitation Medicine, Royal Melbourne Hospital, Parkville, VIC, Australia.

Department of Medicine (Royal Melbourne Hospital), University of Melbourne, Parkville, VIC, Australia.

出版信息

NeuroRehabilitation. 2019;45(1):67-78. doi: 10.3233/NRE-192722.

Abstract

BACKGROUND

There are limited evidence of instrumented measures of gait and balance to determine the functional effects of botulinum toxin injections (BoNT-A) in spasticity after stroke.

OBJECTIVE

To evaluate the functional changes in gait and balance following upper limb and lower limb BoNT-A in persons with stroke.

METHODS

A pre-post prospective study of 35 stroke patients with upper and/or lower limb spasticity after focal treatment with BoNT-A. Assessments were at baseline (T0), 6-weeks (T1) and 12-weeks (T2), using validated subjective and objective physical activity measures.

RESULTS

After BoNT-A injections, significant improvements in most measures of impairments, activity and participation domains were found at T1 (p < 0.05, effect sizes (r) = 0.5-0.9). There was a significant increase in low intensity physical activity (at T1) and sedentary time reductions at both follow-up periods. Instrumented gait/balance measures showed a significant increase in cadence and turn velocity, but no changes in sway measures were found using posturography. Improvements in most outcome measures were maintained at 12-weeks.

CONCLUSION

BONT-A improved scores in most clinical measures but only in some of the objective gait/balance and physical activity measures. Further robust studies should utilize a larger sample size to better determine the benefits of BoNT-A for stroke-related spasticity.

摘要

背景

在痉挛性脑卒中后,使用仪器测量步态和平衡来评估肉毒毒素注射(BoNT-A)的功能效果的证据有限。

目的

评估上肢和下肢 BoNT-A 治疗脑卒中后痉挛患者的步态和平衡功能变化。

方法

一项前瞻性研究,纳入 35 例脑卒中后出现上肢和/或下肢痉挛的患者,在接受 BoNT-A 局部治疗后进行评估。使用经过验证的主观和客观的身体活动测量方法,在基线(T0)、6 周(T1)和 12 周(T2)进行评估。

结果

BoNT-A 注射后,在 T1 时,损伤、活动和参与领域的大多数测量指标均有显著改善(p<0.05,效应大小(r)=0.5-0.9)。在两个随访期,低强度体力活动(T1)和久坐时间减少均有显著增加。仪器化步态/平衡测量显示步速和转弯速度显著增加,但姿势描记法未发现摆动测量的变化。大多数结局指标的改善在 12 周时仍保持。

结论

BoNT-A 可改善大多数临床测量指标,但仅在一些客观步态/平衡和身体活动测量指标中如此。需要进一步的稳健研究,以更好地确定 BoNT-A 对脑卒中相关痉挛的益处,应使用更大的样本量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验